MIT Holding, Inc. (OTCBB: MITD), in collaboration with MEVLABS and Georgia Southern University, have successfully tested prototype designs of the patent pending PROVECTOR™. This small dispensable device is designed to stop the development of pathogens and parasites found in mosquitoes that carry deadly diseases such as malaria, dengue fever, and West Nile virus.
A new study finds treatment for breast cancer differs between African-American women and white women, though the differences are partly dependent on insurance type. The study appears in the November 15, 2007 issue of CANCER, a peer-reviewed journal of the American Cancer Society.
The Stop TB Partnership’s Global Drug Facility and UNITAID announced a collaboration with 19 countries to address life-threatening shortages of anti-tuberculosis drugs.
A combination of drugs widely used to treat infections caused by HIV appears to stop brain damage caused by the virus as well, according to a study published in the Oct. 9, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.
In this retrospective cohort study that included 852 primary care physicians in Quebec, international medical graduates, physicians with high practice volumes and those who were in practice longer were more likely to prescribe antibiotics inappropriately.
Researchers at Cold Spring Harbor Laboratory have discovered three genes that interact with cancerous results in 20 percent of lung cancers. The three genes are located next to each other on human chromosome 14 and two are known to play key roles in fetal lung development.
Depression in the elderly increases the risk of subsequent mental impairment and can act as a predictor of future intellectual decline, University of Rochester Medical Center psychiatrists and researchers have found.
A drug to treat colon cancer is proving much more convenient than traditional chemotherapy, has fewer side effects – and a study of almost 2,000 patients has shown it is giving them a better chance of surviving the disease.
A new study by researchers at Columbia University Mailman School of Public Health finds that folic acid supplements can dramatically lower blood arsenic levels in individuals exposed to arsenic through contaminated drinking water. This toxic element, naturally present in some aquifers used for drinking, is currently a significant public health problem in at least 70 countries, including several developing countries and also parts of the U.S.
A new study finds that white women more frequently take more of the life-prolonging supplemental therapies used to treat breast cancer than African-American women.